Indonesia · Delayed Price · Currency is IDR PT Kimia Farma Tbk Statistics
Total Valuation
IDX:KAEF has a market cap or net worth of IDR 2.53 trillion. The enterprise value is 9.06 trillion.
| Market Cap | 2.53T |
| Enterprise Value | 9.06T |
Important Dates
The next estimated earnings date is Friday, September 4, 2026.
| Earnings Date | Sep 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:KAEF has 5.57 billion shares outstanding.
| Current Share Class | 5.57B |
| Shares Outstanding | 5.57B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.43% |
| Float | 566.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 0.90 |
| P/FCF Ratio | 18.05 |
| P/OCF Ratio | 11.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.00, with an EV/FCF ratio of 64.69.
| EV / Earnings | n/a |
| EV / Sales | 0.95 |
| EV / EBITDA | 21.00 |
| EV / EBIT | n/a |
| EV / FCF | 64.69 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 2.54.
| Current Ratio | 1.03 |
| Quick Ratio | 0.45 |
| Debt / Equity | 2.54 |
| Debt / EBITDA | 16.42 |
| Debt / FCF | 50.58 |
| Interest Coverage | -0.07 |
Financial Efficiency
Return on equity (ROE) is -8.34% and return on invested capital (ROIC) is -0.42%.
| Return on Equity (ROE) | -8.34% |
| Return on Assets (ROA) | -0.17% |
| Return on Invested Capital (ROIC) | -0.42% |
| Return on Capital Employed (ROCE) | -0.39% |
| Weighted Average Cost of Capital (WACC) | 7.33% |
| Revenue Per Employee | 998.09M |
| Profits Per Employee | -23.98M |
| Employee Count | 9,574 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 4.60 |
Taxes
In the past 12 months, IDX:KAEF has paid 3.39 billion in taxes.
| Income Tax | 3.39B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.70% in the last 52 weeks. The beta is 1.04, so IDX:KAEF's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -16.70% |
| 50-Day Moving Average | 446.88 |
| 200-Day Moving Average | 511.62 |
| Relative Strength Index (RSI) | 49.63 |
| Average Volume (20 Days) | 411,085 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:KAEF had revenue of IDR 9.56 trillion and -229.62 billion in losses. Loss per share was -41.25.
| Revenue | 9.56T |
| Gross Profit | 2.98T |
| Operating Income | -39.82B |
| Pretax Income | -250.28B |
| Net Income | -229.62B |
| EBITDA | 293.94B |
| EBIT | -39.82B |
| Loss Per Share | -41.25 |
Balance Sheet
The company has 445.47 billion in cash and 7.08 trillion in debt, with a net cash position of -6,635.95 billion or -1,192.10 per share.
| Cash & Cash Equivalents | 445.47B |
| Total Debt | 7.08T |
| Net Cash | -6,635.95B |
| Net Cash Per Share | -1,192.10 |
| Equity (Book Value) | 2.79T |
| Book Value Per Share | 520.25 |
| Working Capital | 157.19B |
Cash Flow
In the last 12 months, operating cash flow was 216.07 billion and capital expenditures -76.07 billion, giving a free cash flow of 140.00 billion.
| Operating Cash Flow | 216.07B |
| Capital Expenditures | -76.07B |
| Depreciation & Amortization | 333.76B |
| Net Borrowing | -62.04B |
| Free Cash Flow | 140.00B |
| FCF Per Share | 25.15 |
Margins
Gross margin is 31.14%, with operating and profit margins of -0.42% and -2.40%.
| Gross Margin | 31.14% |
| Operating Margin | -0.42% |
| Pretax Margin | -2.62% |
| Profit Margin | -2.40% |
| EBITDA Margin | 3.08% |
| EBIT Margin | -0.42% |
| FCF Margin | 1.47% |
Dividends & Yields
IDX:KAEF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -9.09% |
| FCF Yield | 5.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |